Stocks and securities in focus
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y ▲ |
|---|---|---|---|---|---|---|---|
| AnaptysBio Inc | 8.770% | 27.179% | 31.217% | 29.167% | 27.835% | 27.835% | - |
| X4 Pharmaceuticals, Inc. | 5.830% | -1.469% | -21.219% | -18.712% | 37.564% | - | - |
| Blueprint Medicines Corp | 0.800% | 14.496% | 16.835% | 111.745% | 20.630% | 24.931% | - |
| Cytomx Therapeutics Inc | -0.190% | 174.933% | 108.283% | 175.300% | 195.415% | -47.598% | - |
| Arca Biopharma | -5.290% | - | - | - | - | - | - |
| Viking Therapeutics Inc | 1.050% | 2.938% | -1.243% | 268.454% | 308.808% | 1243.609% | - |
| Voyager Therapeutics Inc | 2.580% | 14.947% | -5.043% | 17.842% | 3.019% | 111.300% | - |
| ImmunityBio Inc. | -0.740% | 23.332% | 60.379% | 178.553% | 79.407% | -40.709% | - |
| Adocia | 1.200% | -0.118% | -2.880% | 190.189% | -28.316% | -7.261% | -53.579% |
| Novavax Inc. | 2.830% | 19.890% | 8.844% | -29.297% | 2.262% | -97.185% | -44.855% |
| Cardiff Oncology Inc. | -20.910% | -14.417% | -33.503% | 93.424% | 148.100% | -58.931% | -6.714% |
| PTC Therapeutics Inc. | 4.030% | 33.621% | 20.155% | -36.735% | 23.016% | -6.061% | -5.025% |
| Gerresheimer AG | -0.200% | 1.592% | -3.770% | 2.459% | 7.814% | 13.444% | 48.078% |
| Amgen Inc. | 10.960% | 14.603% | 14.150% | 39.306% | 10.975% | 42.148% | 83.108% |
| AbbVie Inc. | 1.590% | 1.956% | -7.037% | 12.726% | 8.622% | 60.055% | 116.534% |
| Madrigal Pharmaceuticals inc. | 5.910% | 18.008% | -5.828% | -22.689% | 0.899% | 87.105% | 129.207% |
| United Therapeutics | -0.080% | 10.773% | 14.199% | 23.424% | 22.926% | 43.353% | 172.961% |